Mochida Pharmaceutical Co (TSE:4534) Inventories, Raw Materials & Components: 円13,484 Mil (As of Mar. 2026)


TSE:4534 Mochida Pharmaceutical Co Ltd TSE:4534
69 GF Score
Price 円3,150.00
GF Value 円3,691.00
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Mochida Pharmaceutical Co Inventories, Raw Materials & Components?

Mochida Pharmaceutical Co TSE:4534 -0.47% 69 Inventories, Raw Materials & Components is 円13,484 Mil as of Mar. 2026. GuruFocus rates TSE:4534 with a GF Score™ of 69/100 and a GF Value™ of 円3,691.00 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Mochida Pharmaceutical Co's inventories, raw materials & components for the quarter that ended in Mar. 2026 was 円13,484 Mil.

Mochida Pharmaceutical Co's quarterly raw materials increased from Sep. 2025 (円11,369 Mil) to Dec. 2025 (円12,385 Mil) and increased from Dec. 2025 (円12,385 Mil) to Mar. 2026 (円13,484 Mil).

Mochida Pharmaceutical Co's annual raw materials declined from Mar. 2024 (円10,315 Mil) to Mar. 2025 (円10,314 Mil) but then increased from Mar. 2025 (円10,314 Mil) to Mar. 2026 (円13,484 Mil).

Mochida Pharmaceutical Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Mochida Pharmaceutical Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mochida Pharmaceutical Co Inventories, Raw Materials & Components Chart

Mochida Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,662.00 8,307.00 10,315.00 10,314.00 13,484.00

Mochida Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,314.00 11,018.00 11,369.00 12,385.00 13,484.00
TSE:4534
69GF Score
Mochida Pharmaceutical Co Ltd TSE:4534
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mochida Pharmaceutical Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of 円13,484 Mil mean?
Mochida Pharmaceutical Co (TSE:4534) has a Inventories, Raw Materials & Components of 円13,484 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Mochida Pharmaceutical Co and its competitors.
Is Mochida Pharmaceutical Co's Inventories, Raw Materials & Components too high?
Mochida Pharmaceutical Co's current Inventories, Raw Materials & Components is 円13,484 Mil. Overall, Mochida Pharmaceutical Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mochida Pharmaceutical Co's Inventories, Raw Materials & Components compare to ZTS and UTHR?
Mochida Pharmaceutical Co's Inventories, Raw Materials & Components of 円13,484 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Mochida Pharmaceutical Co and its competitors. Mochida Pharmaceutical Co's current Inventories, Raw Materials & Components is 円13,484 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mochida Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Mochida Pharmaceutical Co (TSE:4534) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,691.00, compared to a current price of 円3,150.00 — trading 14.7% below its estimated fair value. The current Inventories, Raw Materials & Components is 円13,484 Mil. Mochida Pharmaceutical Co's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Mochida Pharmaceutical Co (TSE:4534), the current Inventories, Raw Materials & Components is 円13,484 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mochida Pharmaceutical Co (TSE:4534) Overvalued in 2026?

Based on GuruFocus' analysis, Mochida Pharmaceutical Co stock appears to be undervalued. The current stock price of 円3,150.00 is trading 14.7% below its estimated GF Value™ of 円3,691.00. GuruFocus considers Mochida Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4534:

  • Inventories, Raw Materials & Components: 円13,484 Mil
  • GF Value™: 円3,691.00 vs. price of 円3,150.00 (14.7% below fair value)
  • GF Score™: 69/100 with 4 warning signs

No single metric tells the full story. See the TSE:4534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mochida Pharmaceutical Co Business Description

Address 1-1 Ichigayahonmuracho, Shinjuku-ku, Tokyo, JPN, 162-0845
Mochida Pharmaceutical Co Ltd is a major drug manufacturing company that operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of innovative new drugs. One of Mochida's main objectives is to maximize the business performance of its drugs after they are developed and released. The company also creates skin care products for the general public, and these are supplied through pharmacies, drugstores, and mail-order sales.
69GF Score

Get the complete analysis for TSE:4534

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,150.00
Price
円3,691.00
GF Value